Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma

被引:12
|
作者
Kalac, Matko [1 ,2 ,11 ]
Jain, Salvia [3 ]
Tam, Constantine S. [4 ,5 ]
Xiao, Zhengrui [6 ]
Montanari, Francesca [7 ]
Kanakry, Jennifer [8 ]
Huber, Bryan D. [9 ]
Goldfinger, Mendel [6 ]
O'Connor, Owen A.
Marchi, Enrica [10 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Hematol & Oncol, New York, NY USA
[2] Univ Calif Irvine, Dept Hematol & Oncol, Irvine, CA USA
[3] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[4] Monash Univ, Melbourne, Vic, Australia
[5] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia
[6] Albert Einstein Coll Med, Dept Med, New York, NY USA
[7] Yale Univ Canc Ctr, Dept Hematol, Greenwich, CT USA
[8] NCI, Expt Transplantat & Immunotherapy Branch, NIH, Bethesda, MD USA
[9] Intermt Med Grp, Blood & Marrow Transplant Acute Leukemia Program, Salt Lake City, UT USA
[10] Univ Virginia Canc Ctr, Div Hematol & Oncol, Charlottesville, VA USA
[11] Univ Calif Irvine, Tisch Canc Inst, 200 S Manchester Ave, Orange, CA 92868 USA
关键词
MUTATIONS; TET2;
D O I
10.1182/bloodadvances.2022009445
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:3760 / 3763
页数:4
相关论文
共 50 条
  • [1] A real-world experience of combined treatment with romidepsin and azacitidine in patients with peripheral T-cell lymphoma.
    Kalac, Matko
    Tam, Constantine Si Lun
    Goldfinger, Mendel
    Xiao, Zhengrui
    Rajeeve, Sridevi
    Montanari, Francesca
    Kanakry, Jennifer Ann
    O'Connor, Owen
    Marchi, Enrica
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] A Real World Experience of Combined Treatment with Romidepsin and Azacitidine in Patients with Peripheral T-Cell Lymphoma
    Kalac, Matko
    Tam, Constantine Si Lun
    Goldfinger, Mendel
    Xiao, Zhengrui
    Montanari, Francesca
    Kanakry, Jennifer A.
    O'Connor, Owen
    Marchi, Enrica
    BLOOD, 2021, 138
  • [3] A Real World Experience of Combined Treatment with Romidepsin and Azacitidine in Patients with Peripheral T-Cell Lymphoma - a Bridge to Transplant and an Effective Salvage for the Unfit
    Kalac, Matko
    Jain, Salvia
    Tam, Constantine S.
    Goldfinger, Mendel
    Xiao, Zhengrui
    Montanari, Francesca
    Huber, Bryan D.
    Kanakry, Jennifer A.
    O'Connor, Owen A.
    Marchi, Enrica
    BLOOD, 2022, 140 : 9422 - 9424
  • [4] Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
    Iyer, Swaminathan P.
    Foss, Francine F.
    ONCOLOGIST, 2015, 20 (09): : 1084 - 1091
  • [5] Romidepsin for peripheral T-cell lymphoma
    Khot, Amit
    Dickinson, Michael
    Prince, H. Miles
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 351 - 359
  • [6] Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma
    Irle, Claudius
    Weintraub, Jonathan
    CASE REPORTS IN HEMATOLOGY, 2016, 2016
  • [7] The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience
    Rohlfing, Sarah
    Dietrich, Sascha
    Witzens-Harig, Mathias
    Hegenbart, Ute
    Schoenland, Stefan
    Luft, Thomas
    Ho, Anthony D.
    Dreger, Peter
    ANNALS OF HEMATOLOGY, 2018, 97 (07) : 1241 - 1250
  • [8] The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience
    Sarah Rohlfing
    Sascha Dietrich
    Mathias Witzens-Harig
    Ute Hegenbart
    Stefan Schönland
    Thomas Luft
    Anthony D. Ho
    Peter Dreger
    Annals of Hematology, 2018, 97 : 1241 - 1250
  • [9] Romidepsin In the Treatment of T-Cell Lymphoma
    Yang, Lily P. H.
    DRUGS, 2011, 71 (11) : 1469 - 1480
  • [10] Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
    Woo, Sukyung
    Gardner, Erin R.
    Chen, Xiaohong
    Ockers, Sandra B.
    Baum, Caitlin E.
    Sissung, Tristan M.
    Price, Douglas K.
    Frye, Robin
    Piekarz, Richard L.
    Bates, Susan E.
    Figg, William D.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1496 - 1503